GC WellBeing

CompanySouth Korea

GC WellBeing develops one asset. Mostly small molecule; based in South Korea.

1
Asset
Furthest stage
Not known
0
Trials
2
Signals

Pipeline

1
  • RZL-012

    Injectable small molecule that destroys fat cells to reduce localized fat.

    Stage not known, Small molecule

Full company profiles: pipeline, trials, funding and people.

See Pro

In the full profile

  • Signals2

Intelligence